Hansen Medical, Inc. (HNSN)
Receipt of 510(k) Clearance for the Magellan Robotic System Conference Call
June 4, 2012 17:00 ET
Peter Mariani – Chief Financial Officer
Bruce Barclay – President and Chief Executive Officer
Joe Guido – Vice President, Marketing and Business Development
Brooks West – Piper Jaffray
Jeffrey Cohen – Ladenburg Thalmann
Good day, ladies and gentlemen. Thank you for standing by. Welcome to the Hansen Medical Receipt of Magellan 510(k) Clearance from FDA Conference Call. During today's presentation, all parties will be in a listen-only mode. Following the presentation, the conference will be opened for questions. (Operator Instructions) This conference is being recorded today Monday, June 4, 2012.
I would now like to turn the conference over to Mr. Peter Mariani, Chief Financial Officer. Please go ahead, sir.
Thank you, (Camille). Good afternoon everyone. I am Chief Financial Officer of Hansen Medical. With me today is Bruce Barclay, our President and CEO and Joe Guido, our Vice President of Marketing and Business Development. We have scheduled this call to discuss today FDA announcement related to the FDA 510(k) Clearance of our Magellan Robotic System, NorthStar Robotic Catheter, and related accessories for peripheral, vascular interventions.
As we begin today’s call, please remember that our prepared remarks and responses to questions will contain forward-looking statements that are subject to a number of risks and uncertainties. All statements other than statements of historical fact could be deemed forward-looking statements, including statements containing the words; plan, expects, potential, believe, goal, estimate, anticipate and similar words. These statements are based on the current estimates and assumptions of our management as of the date of this call and are subject to risks, uncertainties, changes and circumstances and other factors that may cause actual results to differ materially from the information expressed or implied by such forward-looking statements.
Check Out Our Best Services for Investors
Jim Cramer and Stephanie Link reveal their investment tactics while giving advanced notice before every trade.
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
Jim Cramer's protégé, David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts